Abstract
Interleukin 2 (IL 2) is a central mediator of the growth and functional activity of B- and T-cells, and cytotoxic cells, including Natural Killer and Lymphokine Activated Killer cells. Significant defects in the production of, and response to, IL 2 have been described in a variety of congenital and acquired immunodeficiency states. IL 2 has demonstrated major anti-tumor activity in animal models. The biochemistry and molecular biology of IL 2 and its gene are reviewed, along with data regarding the IL 2 receptor, normal T-cell activation, abnormalities in IL 2 production and response in immunodeficiency states and leukemia, and initial explorations of IL 2 in the treatment of human cancer.
MeSH terms
-
Acquired Immunodeficiency Syndrome / immunology
-
Acquired Immunodeficiency Syndrome / therapy
-
Amino Acid Sequence
-
Animals
-
Antibodies, Monoclonal
-
Clone Cells
-
DNA Restriction Enzymes
-
Humans
-
Interleukin-2 / immunology
-
Interleukin-2 / metabolism
-
Interleukin-2 / pharmacology
-
Interleukin-2 / physiology*
-
Interleukin-2 / therapeutic use
-
Kinetics
-
Leukemia / immunology
-
Leukemia / therapy
-
Lymphocyte Activation / drug effects
-
Membrane Proteins / metabolism
-
Neoplasms / immunology
-
Neoplasms / therapy
-
Oligonucleotides / analysis
-
RNA, Messenger / metabolism
-
Receptors, Immunologic / metabolism
-
Receptors, Interleukin-2
-
T-Lymphocytes / immunology
Substances
-
Antibodies, Monoclonal
-
Interleukin-2
-
Membrane Proteins
-
Oligonucleotides
-
RNA, Messenger
-
Receptors, Immunologic
-
Receptors, Interleukin-2
-
DNA Restriction Enzymes